You're currently viewing an old version of this dataset. To see the current version, click here.

Malawi Integrated HIV Program Report 2015 Q1

This is the 15th quarterly HIV Program report after implementation of the 2011 Integrated Clinical HIV Guidelines in July 2011. A summary of the key achievements between January and March 2015 is provided below:

  • Scale-up of integrated HIV services had reached the following number of sites:

    • 724 static (579 within and 145 outside of health facilities) and 188 outreach HTC sites

    • 714 (static) ART sites

    • 620 PMTCT sites (Option B+, all included in ART sites above)

    • 657 Pre-ART sites

    • 641 sites with HIV-exposed child follow-up

  • 500,359 persons were tested and counselled for HIV; 157,080 (31%) accessed HTC for the first time; 343,279 (69%) were repeat testers and 9,992 (3%) of these received confirmatory testing (after having tested positive in the past). This is equivalent to 40% confirmatory testing coverage among 25,270 patients initiating ART this quarter. 31,491 (6%) clients received a positive result for the first time.

  • 18,765 (97%) of 19,436 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.

  • 148,838 (91%) of 164,275 women at ANC had their HIV status ascertained; 11,727 (8%) of these were HIV positive. 120,651 (96%) of 129,368 women at maternity had their HIV status ascertained 9,142 (8%) of these were HIV positive.

  • 25,270 patients started ART this quarter.

  • 551,566 patients were alive and on ART by end of March 2015. This means that 55% of the estimated 1 million HIV positive population was on ART. 1 Estimated ART coverage among people in need for treatment1 was 48% (47,962 / 101,000) for children (<15 years) and 65% (503,604 / 779,000) for adults.

  • 76% of adults and 77% of children were retained alive on ART at 12 months after initiation. Actual retention rates are thought to be about 10% higher due to misclassification of ‘silent transfers’ as defaulters in clinic-based survival/retention analysis. (see section 16.4)

  • 481,309 (93%) of 517,067 patients on first line adult ART were on regimen 5A (TDF/3TC/EFV).

  • 11,583 2 (85%) of an estimated 13,317 1 HIV infected pregnant women in Malawi were on ART this quarter. 6,266 (59%) of these were already on ART when getting pregnant and 4,317 (41%) started ART during pregnancy/delivery.

  • An additional 1,584 breastfeeding women started ART due to Option B+ (in WHO stage 1/2)

  • 77%, 72%, 69% and 70% of women started under Option B+ were retained on ART at 6, 12, 24 and 36 months after initiation, respectively.

  • 8,499 (7%) of infants discharged alive from maternity were known to be HIV exposed, 7,866 (93%) of these received ARV prophylaxis (nevirapine). 6,750 (65%) were enrolled in exposed child followup before age 2 months.

  • A total of 10,452 HIV exposed children and 6,223 pre-ART patients were enrolled for follow-up in HIV Care Clinics (HCC) during this quarter.

Data and Resources

Additional Info

Field Value
Program Area Care and Treatment
Year 2015
Author
Author Email